Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 23 Jul 2021 |
2 | Reply to Exam Report (MIS-R) | 09 Aug 2021 |
3 | Documents in support of Show cause Hearing (SCH) | 13 May 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 17 May 2023 |
5 | TM-M(EXTENSION OF TIME) | 17 May 2023 |
1 | Hearing Notice (Show Cause) | 15022770 | 28 Mar 2023 | |
2 | Hearing Notice (Show Cause) | 16004387 | 11 Sep 2023 | |
3 | Hearing Notice (Show Cause) | 16430561 | 02 Nov 2023 | |
4 | Hearing Notice (Show Cause) | 17248161 | 29 Jan 2024 | |
5 | Tribunal Refused Notice for : 5056496 | 17371854 | 6541937 | 10 Feb 2024 |
The application for Broxol was made on 23 July 2021.
The trademark applicant for Broxol is BLISS GVS PHARMA.
Broxol is applied in class(es) 5.
Application for Broxol is on Refused stage.
Application Id allotted to Broxol is 5056496.
Trademark agent or attorney for the application is Innovative Consultants.
Broxol filed with the Intellectual property office as a WORD.